Gastroenteropancreatic Neuroendocrine Tumors: Role of Imaging in Diagnosis and Management
The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Abstract
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a heterogeneous group of neoplasms that arise from cells of the diffuse neuroendocrine system and are characterized by a wide spectrum of clinical manifestations. All NETs are potentially malignant but differ in their biologic characteristics and the probability of metastatic disease. The pathologic classification of these tumors relies on their proliferation and differentiation. In the past decades, several nomenclatures have been proposed to stratify neuroendocrine tumors, but the World Health Organization classification is the one that is most widely accepted and used. The diagnosis of neuroendocrine tumor relies on clinical manifestation, laboratory parameters, imaging features, and tissue biomarkers in a biopsy specimen. With improved understanding of the natural history and lesion biology, management of GEP-NETs has also evolved. Although surgery remains the only potentially curative therapy for patients with primary GEP-NETs, other available treatments include chemotherapy, interferon, somatostatin analogs, and targeted therapies. Recent improvements in both morphologic and functional imaging methods have contributed immensely to patient care. Morphologic imaging with contrast agent-enhanced multidetector computed tomography and magnetic resonance imaging is most widely used for initial evaluation and staging of disease in these patients, whereas functional imaging techniques are useful both for detection and prognostic evaluation and can change treatment planning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of the Digestive System
Bosman, F. T. (2010) · Medical Entomology and Zoology · Cited by 5,041
Yao, J. C., Hassan, M., Phan, A., Dagohoy, C., Leary, C., Mares, J. E., Abdalla, E. K., Fleming, J. B., Vauthey, J.-N., Rashid, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4377 · Cited by 4,510
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
Yao, J. C., Shah, M. H., Ito, T., Bohas, C. L., Wolin, E. M., Van Cutsem, E., Hobday, T. J., Okusaka, T., Capdevila, J., de Vries, E. G. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009290 · Cited by 2,876
A 5‐decade analysis of 13,715 carcinoid tumors
Modlin, I. M., Lye, K. D., & Kidd, M. (2003) · Cancer · doi:10.1002/cncr.11105 · Cited by 2,734
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
Raymond, E., Dahan, L., Raoul, J.-L., Bang, Y.-J., Borbath, I., Lombard-Bohas, C., Valle, J., Metrakos, P., Smith, D., Vinik, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1003825 · Cited by 2,567
Gastroenteropancreatic neuroendocrine tumours
Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V., Caplin, M., Delle Fave, G., Kaltsas, G. A., Krenning, E. P., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70410-2 · Cited by 1,748
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
Rindi, G., Klöppel, G., Alhman, H., Caplin, M., Couvelard, A., de Herder, W. W., Erikssson, B., Falchetti, A., Falconi, M., Komminoth, P., et al. (2006) · Virchows Archiv · doi:10.1007/s00428-006-0250-1 · Cited by 1,547
An analysis of 8305 cases of carcinoid tumors
Modlin, I. M., & Sandor, A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<813::aid-cncr19>3.0.co;2-2 · Cited by 1,200
Klimstra, D. S., Modlin, I. R., Coppola, D., Lloyd, R. V., & Suster, S. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ec124e · Cited by 1,072
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
Ferner, R. E., Huson, S. M., Thomas, N., Moss, C., Willshaw, H., Evans, D. G., Upadhyaya, M., Towers, R., Gleeson, M., Steiger, C., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2006.045906 · Cited by 1,053
Gabriel, M., Decristoforo, C., Kendler, D., Dobrozemsky, G., Heute, D., Uprimny, C., Kovacs, P., Von Guggenberg, E., Bale, R., & Virgolini, I. J. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.035667 · Cited by 1,010
Rindi, G., Klöppel, G., Couvelard, A., Komminoth, P., Körner, M., Lopes, J. M., McNicol, A.-M., Nilsson, O., Perren, A., Scarpa, A., et al. (2007) · Virchows Archiv · doi:10.1007/s00428-007-0452-1 · Cited by 955
Ramage, J. K., Ahmed, A., Ardill, J., Bax, N., Breen, D. J., Caplin, M. E., Corrie, P., Davar, J., Davies, A. H., Lewington, V, et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300831 · Cited by 952
The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors
Lawrence, B., Gustafsson, B. I., Chan, A., Svejda, B., Kidd, M., & Modlin, I. M. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.12.005 · Cited by 861
Histological Typing of Endocrine Tumours
Solcia, E., Klöppel, G., & Sobin, L. H. (2000) · Springer eBooks · doi:10.1007/978-3-642-59655-1 · Cited by 747
Gould, M. K., Kuschner, W. G., Rydzak, C. E., Maclean, C. C., Demas, A. N., Shigemitsu, H., Chan, J. K., & Owens, D. K. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-11-200311180-00013 · Cited by 687
NANETS Treatment Guidelines: Well-Differentiated Neuroendocrine Tumors of the Stomach and Pancreas
Kulke, M. H., Anthony, L. B., Bushnell, D. L., de Herder, W. W., Goldsmith, S. J., Klimstra, D. S., Marx, S. J., Pasieka, J. L., Pommier, R. F., Yao, J. C., et al. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ebb168 · Cited by 574
Boudreaux, J. P., Klimstra, D. S., Hassan, M. M., Woltering, E. A., Jensen, R. T., Goldsmith, S. J., Nutting, C., Bushnell, D. L., Caplin, M. E., & Yao, J. C. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ebb2a5 · Cited by 539
Neuroendocrine tumor epidemiology: Contrasting Norway and North America
Hauso, O., Gustafsson, B. I., Kidd, M., Waldum, H. L., Drozdov, I., Chan, A. K. C., & Modlin, I. M. (2008) · Cancer · doi:10.1002/cncr.23883 · Cited by 505
Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours
Plöckinger, U., Rindi, G., Arnold, R., Eriksson, B., Krenning, E. P., de Herder, W. W., Goede, A., Caplin, M., Öberg, K., Reubi, J. C., et al. (2004) · Neuroendocrinology · doi:10.1159/000085237 · Cited by 477
Kayani, I., Bomanji, J. B., Groves, A., Conway, G., Gacinovic, S., Win, T., Dickson, J., Caplin, M., & Ell, P. J. (2008) · Cancer · doi:10.1002/cncr.23469 · Cited by 477
Virgolini, I., Ambrosini, V., Bomanji, J. B., Baum, R. P., Fanti, S., Gabriel, M., Papathanasiou, N. D., Pepe, G., Oyen, W., De Cristoforo, C., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1512-3 · Cited by 442
Anderson, M. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01272-7 · Cited by 399
Hochwald, S. N., Zee, S., Conlon, K. C., Colleoni, R., Louie, O., Brennan, M. F., & Klimstra, D. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.030 · Cited by 397
Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan
Ito, T., Sasano, H., Tanaka, M., Osamura, R. Y., Sasaki, I., Kimura, W., Takano, K., Obara, T., Ishibashi, M., Nakao, K., et al. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-009-0194-8 · Cited by 394
Dromain, C., de Baere, T., Lumbroso, J., Caillet, H., Laplanche, A., Boige, V., Ducreux, M., Duvillard, P., Elias, D., Schlumberger, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.013 · Cited by 389
Chromogranin A—Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease
Modlin, I. M., Gustafsson, B. I., Moss, S. F., Pavel, M., Tsolakis, A. V., & Kidd, M. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1006-3 · Cited by 387
Adams, S., Baum, R., Rink, T., Schumm-Dräger, P.-M., Usadel, K.-H., & Hör, G. (1997) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050197 · Cited by 387
Rindi, G., Azzoni, C., Rosa, S. L., Klersy, C., Paolotti, D., Rappel, S., Stolte, M., Capella, C., Bordi, C., & Solcia, E. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70174-5 · Cited by 354
Klimstra, D. S., Modlin, I. R., Adsay, N. V., Chetty, R., Deshpande, V., Gönen, M., Jensen, R. T., Kidd, M., Kulke, M. H., Lloyd, R. V., et al. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181ce1447 · Cited by 351
Klöppel, G., Couvelard, A., Perren, A., Komminoth, P., McNicol, A.-M., Nilsson, O., Scarpa, A., Scoazec, J.-Y., Wiedenmann, B., Papotti, M., et al. (2009) · Neuroendocrinology · doi:10.1159/000182196 · Cited by 343
Neuroendocrine tumors metastatic to the liver: How to select patients for liver transplantation?
Mazzaferro, V., Pulvirenti, A., & Coppa, J. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.07.004 · Cited by 334
Imaging of Neuroendocrine Tumors
Heller, M. T., & Shah, A. B. (2011) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2011.02.011 · Cited by 329
Gouya, H., Vignaux, O., Augui, J., Dousset, B., Palazzo, L., Louvel, A., Chaussade, S., & Legmann, P. (2003) · American Journal of Roentgenology · doi:10.2214/ajr.181.4.1810987 · Cited by 312
Sundin, A., Vullierme, M.-P., Kaltsas, G., & Plöckinger, U. (2009) · Neuroendocrinology · doi:10.1159/000184855 · Cited by 287
Anthony, L. B., Strosberg, J. R., Klimstra, D. S., Maples, W. J., O'Dorisio, T. M., Warner, R. R. P., Wiseman, G. A., Benson, A. B., & Pommier, R. F. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ec1261 · Cited by 276
Islet Cell Tumor of the Pancreas: Biphasic CT versus MR Imaging in Tumor Detection
Ichikawa, T., Peterson, M. S., Federle, M. P., Baron, R. L., Haradome, H., Kawamori, Y., Nawano, S., & Araki, T. (2000) · Radiology · doi:10.1148/radiology.216.1.r00jl26163 · Cited by 275
CT Findings in Sclerosing Mesenteritis (Panniculitis): Spectrum of Disease
Horton, K. M., Lawler, L. P., & Fishman, E. K. (2003) · RadioGraphics · doi:10.1148/rg.1103035010 · Cited by 269
Thoeni, R. F., Mueller-Lisse, U. G., Chan, R., Do, N. K., & Shyn, P. B. (2000) · Radiology · doi:10.1148/radiology.214.2.r00fe32483 · Cited by 256
Hatzaras, I. S., Palesty, J. A., Abir, F., Sullivan, P. D., Kozol, R. A., Dudrick, S. J., & Longo, W. E. (2007) · Archives of Surgery · doi:10.1001/archsurg.142.3.229 · Cited by 255
Eriksson, B., Klöppel, G., Krenning, E., Ahlman, H., Plöckinger, U., Wiedenmann, B., Arnold, R., Auernhammer, C., Körner, M., Rindi, G., et al. (2008) · Neuroendocrinology · doi:10.1159/000111034 · Cited by 254
Detection of unknown primary neuroendocrine tumours (CUP-NET) using 68Ga-DOTA-NOC receptor PET/CT
Prasad, V., Ambrosini, V., Hommann, M., Hoersch, D., Fanti, S., & Baum, R. P. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1205-y · Cited by 249
Pancreatic Endocrine Tumors: Radiologic-Clinicopathologic Correlation
Lewis, R. B., Lattin, G. E., & Paal, E. (2010) · RadioGraphics · doi:10.1148/rg.306105523 · Cited by 244
Lebtahi, R., Cadiot, G., Sarda‐Mantel, L., Daou, D., Faraggi, M., Petegnief, Y., Mignon, M., & Guludec, D. L. (1997) · PubMed · Cited by 240
Multimodality Imaging of Neoplastic and Nonneoplastic Solid Lesions of the Pancreas
Low, G., Panu, A., Millo, N., & Leen, E. (2011) · RadioGraphics · doi:10.1148/rg.314105731 · Cited by 240
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors
Ambrosini, V., Campana, D., Bodei, L., Nanni, C., Castellucci, P., Allegri, V., Montini, G. C., Tomassetti, P., Paganelli, G., & Fanti, S. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.071712 · Cited by 232
Zimmer, T., Stölzel, U., Bäder, M., Koppenhagen, K., Hamm, B., Buhr, H., Riecken, E. O., & Wiedenmann, B. (1996) · Gut · doi:10.1136/gut.39.4.562 · Cited by 223
Vagefi, P. A., Razo, O., Deshpande, V., McGrath, D. J., Lauwers, G. Y., Thayer, S. P., Warshaw, A. L., & Castillo, C. F. F.-D. (2007) · Archives of Surgery · doi:10.1001/archsurg.142.4.347 · Cited by 208
Elias, D., Lefevre, J. H., Duvillard, P., Goéré, D., Dromain, C., Dumont, F., & Baudin, E. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181bdf8cf · Cited by 202
The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors
Ducreux, M. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02003-7 · Cited by 196
Öberg, K. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.10.014 · Cited by 189
Khashab, M. A., Yong, E., Lennon, A. M., Shin, E. J., Amateau, S., Hruban, R. H., Olino, K., Giday, S., Fishman, E. K., Wolfgang, C. L., et al. (2011) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2010.08.030 · Cited by 186
Bakker, W. H., Krenning, E. P., Reubi, J.-C., Breeman, W. A. P., Setyono-Han, B., de Jong, M., Kooij, P. P. M., Bruns, C., van Hagen, P. M., Marbach, P., et al. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90053-e · Cited by 174
Diederichs, C. G., Staib, L., Vogel, J., Glasbrenner, B., Glatting, G., Brambs, H.-J., Beger, H. G., & Reske, S. N. (2000) · Pancreas · doi:10.1097/00006676-200003000-00001 · Cited by 167
Cystic Pancreatic Endocrine Neoplasms: A Distinct Tumor Type?
Bordeianou, L., Vagefi, P. A., Sahani, D., Deshpande, V., Rakhlin, E., Warshaw, A. L., & Fernández-del Castillo, C. (2008) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.12.040 · Cited by 166
Self-citationMiederer, M., Seidl, S., Buck, A., Scheidhauer, K., Wester, H.-J., Schwaiger, M., & Perren, A. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0944-5 · Cited by 161
Koh, D., Brown, G., Riddell, A. M., Scurr, E. D., Collins, D. J., Allen, S. D., Chau, I., Cunningham, D., deSouza, N. M., Leach, M. O., et al. (2008) · European Radiology · doi:10.1007/s00330-007-0847-z · Cited by 160
Gibril, F., Reynolds, J. C., Chen, C. C., Yu, F., Goebel, S. U., Serrano, J., Doppman, J. L., & Jensen, R. T. (1999) · PubMed · Cited by 159
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study
Zatelli, M. C., Torta, M., Leon, A., Ambrosio, M. R., Gion, M., Tomassetti, P., De Braud, F., Delle Fave, G., Dogliotti, L., Uberti, E. C. D., et al. (2007) · Endocrine-Related Cancer · doi:10.1677/erc-07-0001 · Cited by 159
MRI of pancreatic neuroendocrine tumours
Owen, N. J., Sohaib, S. A. A., Peppercorn, P. D., Monson, J. P., Grossman, A. B., Besser, G. M., & Reznek, R. H. (2001) · The British Journal of Radiology · doi:10.1259/bjr.74.886.740968 · Cited by 158
Well-Differentiated Gastric Tumors/Carcinomas
Ruszniewski, P., Delle Fave, G., Cadiot, G., Komminoth, P., Chung, D., Kos-Kudla, B., Kianmanesh, R., Hochhauser, D., Arnold, R., Ahlman, H., et al. (2006) · Neuroendocrinology · doi:10.1159/000098007 · Cited by 154
Turaga, K. K., & Kvols, L. K. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20097 · Cited by 146
Arnold, R., Chen, Y.-J., Costa, F., Falconi, M., Gross, D., Grossman, A. B., Hyrdel, R., Kos-Kudła, B., Salazar, R., & Plöckinger, U. (2009) · Neuroendocrinology · doi:10.1159/000225952 · Cited by 145
Wang, Y., Chen, Z. E., Yaghmai, V., Nikolaidis, P., McCarthy, R. J., Merrick, L., & Miller, F. H. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22541 · Cited by 141
Öberg, K., Åkerström, G., Rindi, G., & Jelić, S. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq192 · Cited by 140
Systemic Distribution of Somatostatin Receptor Subtypes in Human: An Immunohistochemical Study
Taniyama, Y., Suzuki, T., Mikami, Y., Moriya, T., Satomi, S., & Sasano, H. (2005) · Endocrine Journal · doi:10.1507/endocrj.52.605 · Cited by 139
Usefulness of CDX2 and TTF-1 in Differentiating Gastrointestinal From Pulmonary Carcinoids
Saqi, A., Alexis, D., Remotti, F., & Bhagat, G. (2005) · American Journal of Clinical Pathology · doi:10.1309/ukn6-pvrk-xhg4-22da · Cited by 128
Small-Bowel Neoplasms: Prospective Evaluation of MR Enteroclysis
Masselli, G., Polettini, E., Casciani, E., Bertini, L., Vecchioli, A., & Gualdi, G. (2009) · Radiology · doi:10.1148/radiol.2513081819 · Cited by 126
EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery
Ardengh, J. C., de Paulo, G. A., & Ferrari, Â. P. (2004) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(04)01807-3 · Cited by 118
Multimodality preoperative imaging of pancreatic insulinomas
McAuley, G., Delaney, H., Colville, J., Lyburn, I. D., Worsley, D. F., Govender, P., & Torreggiani, W. C. (2005) · Clinical Radiology · doi:10.1016/j.crad.2005.06.005 · Cited by 118
Hepatic Neuroendocrine Metastases: Chemo- or Bland Embolization?
Pitt, S. C., Knuth, J., Keily, J. M., McDermott, J. C., Weber, S. M., Chen, H., Rilling, W. S., Quebbeman, E. J., Agarwal, D. M., & Pitt, H. A. (2008) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-008-0640-6 · Cited by 117
Nuclear medicine imaging of neuroendocrine tumours
Bombardieri, E., Maccauro, M., de Deckere, E. R. J. T., Savelli, G., & Chiti, A. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s51 · Cited by 111
Gibril, F., & Jensen, R. T. (2003) · Digestive and Liver Disease · doi:10.1016/j.dld.2003.11.024 · Cited by 108
Meijer, W. G., van der Veer, E., Jager, P. L., van der Jagt, E. J., Piers, B. A., Kema, I. P., de Vries, E. G. E., & Willemse, P. H. B. (2003) · PubMed · Cited by 106
Value of CT Enteroclysis in Suspected Small-Bowel Carcinoid Tumors
Kamaoui, I., Deluca, V., Ficarelli, S., Mennesson, N., Lombard‐Bohas, C., & Pilleul, F. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.09.2760 · Cited by 104
Practical Markers Used in the Diagnosis of Neuroendocrine Tumors
Lloyd, R. V. (2003) · Endocrine Pathology · doi:10.1385/ep:14:4:293 · Cited by 103
Schillaci, O., Spanu, A., Scopinaro, F., Falchi, A., Danieli, R., Marongiu, P., Pisu, N., Madeddu, G., Fave, G. D., & Madeddu, G. (2003) · PubMed · Cited by 102
Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes
Lodish, M. B., & Stratakis, C. A. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.02.002 · Cited by 100
Imaging of Neuroendocrine Tumors
Tamm, E. P., Kim, E. E., & Ng, C. S. (2007) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2007.04.006 · Cited by 100
Imaging of gastroenteropancreatic neuroendocrine tumors
Tan, E. H., & Tan, C. H. (2010) · World Journal of Clinical Oncology · doi:10.5306/wjco.v2.i1.28 · Cited by 97
Developments in PET for the detection of endocrine tumours
Eriksson, B., Örlefors, H., Öberg, K., Sundín, A., Bergström, M., & Långström, B. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.11.001 · Cited by 95
Standardisation of imaging in neuroendocrine tumours: results of a European delphi process
Ricke, J., Klose, K.-J., Mignon, M., Öberg, K., & Wiedenmann, B. (2001) · European Journal of Radiology · doi:10.1016/s0720-048x(00)00187-x · Cited by 92
CT and MR imaging findings of endocrine tumor of the pancreas according to WHO classification
Rha, S. E., Jung, S. E., Lee, K. H., Ku, Y. M., Byun, J. Y., & Lee, J. M. (2007) · European Journal of Radiology · doi:10.1016/j.ejrad.2007.02.036 · Cited by 91
Waldmann, J., Fendrich, V., Habbe, N., Bartsch, D. K., Slater, E. P., Kann, P. H., Rothmund, Μ., & Langer, P. (2009) · World Journal of Surgery · doi:10.1007/s00268-009-9983-8 · Cited by 89
Neuroendocrine tumors of the small bowels are on the rise: Early aspects and management
Scherübl, H. (2010) · World Journal of Gastrointestinal Endoscopy · doi:10.4253/wjge.v2.i10.325 · Cited by 89
MRI of Islet Cell Tumors of the Pancreas
Herwick, S. M., Miller, F. H., & Keppke, A. L. (2006) · American Journal of Roentgenology · doi:10.2214/ajr.05.0809 · Cited by 83
EUS-FNA predicts 5-year survival in pancreatic endocrine tumors
Figueiredo, F. A. F., Giovannini, M. F., Monges, G. M., Bories, E., Pésenti, C., Caillol, F., & Delpéro, J. (2009) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2009.05.020 · Cited by 82
Cimitan, M., Buonadonna, A., Cannizzaro, R., Canzonieri, V., Borsatti, E., Ruffo, R., & Appollonia, L. D. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg279 · Cited by 76
Detection of Neuroendocrine Tumors of the Small Bowel by Double Balloon Enteroscopy
Bellutti, M., Fry, L. C., Schmitt, J., Seemann, M. D., Klose, S., Malfertheiner, P., & Mönkemüller, K. E. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0456-y · Cited by 75
Neuroendocrine Neoplasms of the Gastrointestinal Tract
Schott, M., Klöppel, G., Raffel, A., Saleh, A., Knoefel, W. T., & Scherbaum, W. A. (2011) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2011.0305 · Cited by 74
Barbe, C., Murat, A., Dupas, B., Ruszniewski, P. B., Tabarin, A., Vullierme, M., Penfornis, A., Rohmer, V., Baudin, É., Rhun, M. L., et al. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.09.014 · Cited by 73
Molecular Genetics of Gastroenteropancreatic Neuroendocrine Tumors
Toumpanakis, C., & Caplin, M. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01777.x · Cited by 72
Treatment of Liver Metastases in Patients with Neuroendocrine Tumors: A Comprehensive Review
Harring, T. R., Nguyen, N. T. N., Goss, J. A., & O'Mahony, C. A. (2011) · International Journal of Hepatology · doi:10.4061/2011/154541 · Cited by 69
Vossen, J. A., Buijs, M., Liapi, E. A., Eng, J., Bluemke, D. A., & Kamel, I. R. (2008) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0b013e31816a6823 · Cited by 69
Shapiro, R., Eldar, S. M., Sadot, E., et al. (2011) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2010.04.016 · Cited by 63
von Hippel-Lindau (VHL) Disease: An Update on the Clinico-pathologic and Genetic Aspects
Shehata, B. M., Stockwell, C. A., Castellano-Sanchez, A. A., Setzer, S. V., Schmotzer, C. L., & Robinson, H. B. (2008) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e31816f852e · Cited by 54
CT imaging spectrum of pancreatic serous tumors: Based on new pathologic classification
Sun, H. Y., Kim, S. H., Kim, M. A., Lee, J., Han, J. K., & Choi, B. I. (2010) · European Journal of Radiology · doi:10.1016/j.ejrad.2009.11.017 · Cited by 47
Intrapancreatic Accessory Spleen: Clinicopathologic Analysis of 12 Cases
Hwang, H. S., Lee, S. S., Kim, S. C., Seo, D. W., & Kim, J. (2011) · Pancreas · doi:10.1097/mpa.0b013e318216815b · Cited by 43
Contrast-Enhanced Endoscopic Ultrasonography Improves the Preoperative Localization of Insulinomas
Kasono, K., Hyodo, T., SUMINAGA, Y., 杉浦寧子, Namai, K., Ikoma, A., Tamemoto, H., Imawari, M., Kawakami, M., & Ishikawa, S. (2002) · Endocrine Journal · doi:10.1507/endocrj.49.517 · Cited by 36
Palazzo, L., Roseau, G., Chaussade, S., Salmerón, M. D. B., Gaudric, M., & Paolaggi, J. A. (1993) · PubMed · Cited by 28
Molecular Imaging of Gastroenteropancreatic Neuroendocrine Tumors
Miederer, M., Weber, M. M., & Fottner, C. (2010) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.08.031 · Cited by 23
Kuiper, P., Verspaget, H. W., Overbeek, L. I. H., Biemond, I., & Lamers, C. B. H. W. (2011) · PubMed · Cited by 18
Surgery for Gastroenteropancreatic Neuroendocrine Tumors (GEPNETS)
Boudreaux, J. P. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.12.004 · Cited by 15
New Pharmacologic Therapies for Gastroenteropancreatic Neuroendocrine Tumors
Lawrence, B. J., Gustafsson, B. I., Kidd, M. S., & Modlin, I. M. (2010) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.08.013 · Cited by 14
Metadata
- Authors
- Sahani, D. V., Bonaffini, P. A., Fernández–Del Castillo, C., & Blake, M. A.
- Venue
- Radiology
- Published
- 2013-01
- Volume
- 266
- Issue
- 1
- Pages
- 38-61
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2162792851
- Cited by
- 191
- References
- 104
- FWCI
- 5.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.